Lowell Therapeutics

About:

Lowell Therapeutics is a pharmaceutical company that develops products for critically ill patients.

Website: https://ltx.life

Description:

Lowell Therapeutics is a pharmaceutical company that develops products for critically ill patients. It develops an anticoagulant for critically ill patients in the ICU who experience kidney failure and need to go on an artificial kidney machine called continuous renal replacement therapy (CRRT), which is 24/7 dialysis. This machine involves circulating blood outside the patient through a filter. Eventually, blood will clot in the filter unless it is anticoagulated. When the filter clogs, doctors and nurses must stop the machine to change it – throwing away clotted blood and in the process, increasing blood loss and the need for transfusions.

Total Funding Amount:

$4.05M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lowell, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)ltx.life

Founders:

James Wilkie

Number of Employees:

1-10

Last Funding Date:

2021-10-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai